Biotangents develops diagnostic assays for infectious diseases in veterinary medicine, focusing on detecting genetic markers of disease. Its AmpliSpec platform is a LAMP-based veterinary diagnostics platform delivering lab-quality results in under two hours at point of care. Products include AmpliSpec Go Mastitis for farm-level pathogen diagnosis, AmpliSpec Benchtop Mastitis for labs, and AmpliSpec Benchtop BVD for bovine viral diarrhea detection. Founded in 2015 in Edinburgh, United Kingdom, the company has raised $5.6M in Series A funding from investors including Eos Advisory, Kelvin Capital, and Scottish Enterprise. Developer of diagnostic assays for infectious diseases in veterinary medicine. It focuses on creating approaches for detecting genetic markers of disease. The company engineers methods of sample processing for infectious disease detection.
← All startups
Biotangents
Series ABiotangents develops diagnostic assays for infectious diseases in veterinary medicine, focusing on detecting genetic markers of disease. Its AmpliSpec platform is a LAMP-based veterinary diagnostics platform delivering lab-quality results in under two hours at point of care. Products include AmpliSpec Go Mastitis for farm-level pathogen diagnosis, AmpliSpec Benchtop Mastitis for labs, and AmpliSpec Benchtop BVD for…
About
Business model
Veterinary HealthTech > In Vitro Diagnostics > Diversified,
Genomics > Enabling Technologies > Kits and Reagents > Bioreagents
Team background
College Wise > University of Oxford
Institutional investors
Eos AdvisoryBritish Business InvestmentsKelvin CapitalScottish EnterpriseScottish Investment BankGovGogrowInnova PartnershipsCastle ViewMacro RobertsGreendrumJohn BoyceIan HamiltonSarah HaleRobert Boyce
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.